About

// Our Vision

Who We Are

We aim to empower researchers and students with advanced computational tools for innovative drug discovery and bioinformatics solutions.

CompChem Hub is a research-driven institute dedicated to computational drug discovery, bioinformatics, and scientific training. We provide hands-on mentorship, academic project support, and innovative solutions for researchers and students. We use molecular modeling, data analysis, and experimental design to deliver high-quality research and make meaningful contributions to science and healthcare.

// How we Serve you

Our Simplified Process

Expert-Led Training Programs

CompChem Hub specializes in CADD, Bioinformatics, and Capacity Building services, empowering researchers and students to advance their drug discovery and computational sciences knowledge.

Comprehensive Research Support

We provide end-to-end assistance for academic projects, including experimental design, data analysis, and scientific writing. ensuring high-quality research output.

Personalized Learning Experiences

Our structured courses and mentorship programs are tailored to fit your skill level, career goals, and academic research needs.

Abdeen Tunde Ogunlana

// meet the ceo

Abdeen Tunde Ogunlana is a Biochemist specializing in Computer-Aided Drug Design. He has co-authored significant research studies and served as a peer reviewer for top scientific journals. His work combines computational techniques with applications in medicine and pharmaceuticals, contributing to the advancement of drug design. Abdeen has presented at prestigious conferences and has mentored students while collaborating on recognized projects. His ongoing contributions inspire future developments in drug design.

Ojo Taiwo Ooreoluwa

// Training Director

Taiwo Ooreoluwa Ojo is a passionate researcher and Biochemist specializing in drug discovery, medicinal chemistry, and genome study. With expertise in Computational Chemistry/Biology, Bioinformatics, and Immunoinformatics, Taiwo has led groundbreaking studies, including gene silencing for multiple sclerosis and drug discovery for neuro-related diseases. He is a recipient of numerous awards and aims to advance translational research and mentor future scientists

Bolaji Olawale Quadri

// Research director

Olawale Quadri Bolaji has a strong background in
Biochemistry with vast experience in Computer-aided drug discovery, Molecular Biology, and Medicinal Chemistry. He has led and contributed to various research studies on cancer, malaria, and sickle cell disease. To his archive, Olawale has discovered novel drug candidates whose reports have been published in reputable journals. He is a seasoned conference speaker and trainer. As a mentor, Olawale has guided students and collaborated on award-winning projects.

// Our research Team

Beyond our founding members, we also partner with several experts in the field of Bio-Informatics.

Oyaronbi Adegboye Oyewole

// Research Associates

Adegboye Oyaronbi is a biochemistry graduate with strong expertise in molecular docking and bio-informatics. He has co-authored research on microbial therapies, therapeutic peptides, and drug design, showcasing a solid foundation in computational biology. With over two years of experience as a research assistant and more than three years organizing specialized training, he is passionate about scientific education and innovation. Adegboye is dedicated to advancing drug discovery through research, collaboration, and the continuous development of practical, data-
ariven solutions.

Danstan Kabuuka

// Research Associates

Danstan is a Bioinformatics Scientist with a background in virology and immunology. He holds an MSc in Bioinformatics, his recent works focus on genomics, molecular diagnostics, and genomic surveillance. His research focuses on understanding viral mutations, pathogen evolution, and using genomic approaches to support vaccine and therapeutic development. Danstan currently applies computational tools such as AlphaFold for protein structure prediction to guide vaccine research and biologics discovery.

Ifeoma Mirabel Udo

// Research Associates

Mirabel is a Biochemistry graduate passionate about research, drug discovery, and personalized medicine. She’s interested in how biological systems can be studied more deeply to uncover insights that improve healthcare and treatment strategies.

Mirabel have a growing curiosity for biomedical research and data-driven approaches to understanding disease. She enjoys learning how information from experiments and analysis can be used to guide better scientific decisions. She sees science as a continuous process of learning and contribution, with the goal of creating meaningful impact in healthcare.

Lilian Nwagbara

// Research Associates

Lilian bridges the worlds of biology and computation, working at the intersection of genomics and computer-aided drug design (CADD). From variant calling and phylogenetics to molecular docking and pharmacophore modeling, I use bioinformatics tools to uncover insights that support drug discovery and biomedical research.

I’m equally passionate about collaboration and training, whether writing research outputs, facilitating workshops, or learning from peers. For me, science is about more than data; it’s about building communities of knowledge and applying discoveries to improve lives.

Albashir Tahir

// Research Associates

Tahir is a pharmacologist, researcher, and lecturer in the Department of Pharmacology, Faculty of Basic Medical Sciences, Sa’adu Zungur University, Bauchi State, Nigeria. His research integrates pharmacology, computational drug discovery, and natural product science, with a particular focus on identifying and optimizing bioactive compounds from African medicinal plants for the treatment of infectious and non-communicable diseases. His expertise includes molecular docking, virtual screening, ADMET prediction, drug-likeness assessment, and phytochemical characterization, employing both experimental and in silico approaches to accelerate therapeutic discovery. Tahir has authored and co-authored more than 30 peer-reviewed publications spanning computational pharmacology, pharmacognosy, medicinal chemistry, toxicology, and public health. Through his research and teaching, he is committed to advancing evidence-based pharmacology, bridging ethnomedicinal knowledge with modern drug development, and training the next generation of pharmaceutical and biomedical scientists.

Abdul Aziz Khaled

// Research Associates

Khaled is a researcher with a multidisciplinary background in structural biology, protein engineering, and molecular biology. Shaped by curiosity, seeking to unravel complex molecular mechanisms. His research skills includes the integration of structural bioinformatics, computer-aided drug design & discovery (CADD), and NGS data analysis such as Bulk RNA-seq, scRNA-seq, and metagenomics with wet lab, which will allow the development and promotion of knowledge that benefits human health.

Okikiola Olamide Olanrewaju

// Research Associates

Okikiola is a Biochemist, Molecular Biology Researcher, and Bioinformatics Scientist with expertise in molecular medicine, genomics, biotechnology, and computational drug discovery. He holds a B.Sc. in Biochemistry from Kwara State University and is pursuing an M.Sc. in Biochemistry (Molecular Biology) at Babcock University. His research combines laboratory and computational approaches to study disease mechanisms and identify therapeutic targets. His interests include molecular diagnostics, pharmacogenetics, personalized medicine, molecular docking, network pharmacology, vaccine design, and bioinformatics-driven drug discovery. He is skilled in PCR, nucleic acid extraction, protein analysis, primer design, and assay development.

Rayan Yousif

// Research Associates

Rayan is a senior pharmacy student at the University of Gezira and an aspiring researcher focused on drug discovery, medicinal chemistry, and bioinformatics. Passionate about innovation, I specialize in Computer-Aided Drug Design (CADD) and hold a leadership role within the Project Management Office of the Pharmaceutical Research Association (PRA). As a recognized leader in the pharma and biotech content space, I engage a community of 11,000 followers on LinkedIn by sharing scientific insights and advocating for advancements in healthcare. My goal is to bridge the gap between academic research and practical, tech-driven pharmaceutical solutions to shape the future of the industry.

Abdulbasit Abdulrazak

// Research Associates

Abdulbasit is a research-driven Biochemist passionate about advancing healthcare innovation, medicines’ security, and evidence-based public health solutions. His work focuses on Computer Aided Drug Design, Phytochemistry, Bioinformatics, health systems strengthening, and promoting clinical research acceptance in Nigeria and across Africa.

Complementing his research background, He possess growing software engineering and digital innovation skills that support data-driven health solutions, with skills in web development (HTML, CSS, JavaScript), Git/GitHub, AI tools for research productivity, and graphic design for scientific communication and advocacy.

Beyond research, He is committed to youth engagement, gender inclusion, and stakeholder-driven health advocacy. He is interested in collaborations that drive pharmaceutical innovation, digital health solutions, and equitable access to healthcare.

Olawuyi Matthew Oluwaseun

// Research Associates

Matthew is a molecular biologist, biochemist, and computational researcher with interests in bioinformatics, pharmacology, drug discovery, and molecular modeling. He obtained a B.Tech degree in Biochemistry from Ladoke Akintola University of Technology (LAUTECH), Ogbomoso. He is currently pursuing an M.Sc. in Pharmacology and Therapeutics at the University of Abuja, where he is expanding his expertise in drug action, therapeutics, and translational research.

Matthew’s research interests include bioinformatics, molecular docking, genomics, machine learning in drug discovery, and computational approaches to disease management. He has contributed to research on Epstein–Barr virus-induced multiple sclerosis and AI-generated inhibitors targeting KRASG12D in pancreatic cancer. As a Research Assistant at CompChem Hub, he applies computational tools to biomedical research and remains committed to scientific innovation, collaboration, and the advancement of healthcare research.